Oncologist and organizational factors associated with variation in breast cancer multigene testing.
Tracy A LieuG Thomas RayStephanie R PrausnitzLaurel A HabelStacey AlexeeffYan LiScott D RamseyCharles E PhelpsNeetu ChawlaSuzanne C O'NeillJeanne S MandelblattPublished in: Breast cancer research and treatment (2017)
Oncologist and leadership practices play a key role in the variation in genomic test use for cancer recurrence risk even in a healthcare system without financial barriers to testing and could be a leverage point for implementing desired practice changes for new genomic advances.